These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1315 related articles for article (PubMed ID: 19877724)
21. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Hong T; Zhang M; Fan J Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009698. PubMed ID: 26457607 [TBL] [Abstract][Full Text] [Related]
22. Conversion to Everolimus in Kidney Transplant Recipients With Calcineurin Inhibitor-Induced Nephropathy: 3 Case Reports. Nanmoku K; Shinzato T; Kubo T; Shimizu T; Yagisawa T Transplant Proc; 2019 Jun; 51(5):1424-1427. PubMed ID: 31060742 [TBL] [Abstract][Full Text] [Related]
23. Conversion to everolimus in kidney transplant recipients: to believe or not believe? Cotovio P; Neves M; Santos L; Macário F; Alves R; Mota A Transplant Proc; 2012 Dec; 44(10):2966-70. PubMed ID: 23195007 [TBL] [Abstract][Full Text] [Related]
24. Calcineurin inhibitor-free protocols: risks and benefits. Barbari AG; Stephan AG; Masri MA Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):1-23. PubMed ID: 17237886 [TBL] [Abstract][Full Text] [Related]
25. The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant. Boswell A; Evans L; Rigg K; Shehata M Transplant Proc; 2005 Mar; 37(2):884-5. PubMed ID: 15848564 [TBL] [Abstract][Full Text] [Related]
26. Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial. Budde K; Prashar R; Haller H; Rial MC; Kamar N; Agarwal A; de Fijter JW; Rostaing L; Berger SP; Djamali A; Leca N; Allamassey L; Gao S; Polinsky M; Vincenti F J Am Soc Nephrol; 2021 Dec; 32(12):3252-3264. PubMed ID: 34706967 [TBL] [Abstract][Full Text] [Related]
27. Immunosuppressive treatment and progression of histologic lesions in kidney allografts. Morales JM Kidney Int Suppl; 2005 Dec; (99):S124-30. PubMed ID: 16336565 [TBL] [Abstract][Full Text] [Related]
28. Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates. Nakamura K; Oshima S; Maeda M; Morio H; Fukahori H; Nakanishi T; Tsujimoto S; Hirose J; Noto T; Hamakawa N; Inami M; Morokata T Int Immunopharmacol; 2018 Nov; 64():201-207. PubMed ID: 30195818 [TBL] [Abstract][Full Text] [Related]